Electronic Monitoring and Improvement of Adherence to DOACs in Polymedicated Stroke Patients (MAAESTRO)
Electronic Monitoring and Improvement of Adherence to Direct Oral Anticoagulant Treatment - a Randomised Crossover Study of an Educational and Reminder-based Intervention in Ischaemic Stroke Patients Under Polypharmacy
Sponsor: Clinical Trial Unit, University Hospital Basel, Switzerland
A NA clinical study on Adherence, Patient and Stroke, Ischemic, this trial is completed. The trial is conducted by Clinical Trial Unit, University Hospital Basel, Switzerland and has accumulated 11 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jun 2022 — Jan 2023 [monthly]
Recruiting NA
-
May 2021 — Jun 2022 [monthly]
Recruiting NA
▶ Show 6 earlier versions
-
Jan 2021 — May 2021 [monthly]
Recruiting NA
-
Jun 2020 — Jan 2021 [monthly]
Recruiting NA
-
Jun 2019 — Jun 2020 [monthly]
Recruiting NA
-
Jun 2018 — Jun 2019 [monthly]
Recruiting NA
-
Feb 2018 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Dec 2017 — Feb 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Clinical Trial Unit, University Hospital Basel, Switzerland
- University Hospital, Basel, Switzerland
- University of Basel
For direct contact, visit the study record on ClinicalTrials.gov .